O-GlcNAcase: Promiscuous hexosaminidase or key regulator of O-GlcNAc signaling?

Journal of Biological Chemistry

Volumn 289, Issue 50, 2014, Pages 34433-34439

  Alonso, Jana ^a   Schimpl, Marianne ^a   Van Aalten, Daan M F ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOCHEMISTRY;

C-TERMINAL DOMAINS; HEXOSAMINIDASE; KEY REGULATORS; KNOCK OUTS; OVER-EXPRESSION; PHYSIOLOGICAL FUNCTIONS;

ENZYMES;

BETA N ACETYLHEXOSAMINIDASE; ENZYME INHIBITOR; O GLCNACASE; O GLCNACASE INHIBITOR; REGULATOR PROTEIN; UNCLASSIFIED DRUG; HEXOSAMINIDASE C; N ACETYLGLUCOSAMINE;

BINDING AFFINITY; BINDING SITE; CARBOXY TERMINAL SEQUENCE; DATA ANALYSIS; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME STRUCTURE; HUMAN; MOLECULAR DYNAMICS; NONHUMAN; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN HYDROLYSIS; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMISTRY; ENZYME SPECIFICITY; GENETICS; METABOLISM;

ACETYLGLUCOSAMINE; ANIMALS; BETA-N-ACETYLHEXOSAMINIDASES; ENZYME INHIBITORS; HUMANS; SIGNAL TRANSDUCTION; SUBSTRATE SPECIFICITY;

EID: 84919337950     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.R114.609198     Document Type: Review

References (83)

1. Torres, C. R., and Hart, G. W. (1984) Topography and polypeptide distribution of terminal N-acetylglucosamine residues on the surfaces of intact lymphocytes. Evidence for O-linked GlcNAc. J. Biol. Chem. 259, 3308-3317
2. Zachara, N. E., and Hart, G. W. (2004) O-GlcNAc a sensor of cellular state: the role of nucleocytoplasmic glycosylation in modulating cellular function in response to nutrition and stress. Biochim. Biophys. Acta 1673, 13-28
3. Housley, M. P., Rodgers, J. T., Udeshi, N. D., Kelly, T. J., Shabanowitz, J., Hunt, D. F., Puigserver, P., and Hart, G. W. (2008) O-GlcNAc regulates FoxO activation in response to glucose. J. Biol. Chem. 283, 16283-16292
4. Hanover, J. A., Krause, M. W., and Love, D. C. (2012) Bittersweet memories: linking metabolism to epigenetics through O-GlcNAcylation. Nat. Rev. Mol. Cell Biol. 13, 312-321
5. Howerton, C. L., Morgan, C. P., Fischer, D. B., and Bale, T. L. (2013) O-GlcNAc transferase (OGT) as a placental biomarker of maternal stress and reprogramming of CNS gene transcription in development. Proc. Natl. Acad. Sci. U.S.A. 110, 5169-5174
6. Ruan, H. B., Singh, J. P., Li, M. D., Wu, J., and Yang, X. (2013) Cracking the O-GlcNAc code in metabolism. Trends Endocrinol. Metab. 24, 301-309
7. Müller, R., Jenny, A., and Stanley, P. (2013) The EGF repeat-specific O-GlcNAc-transferase Eogt interacts with notch signaling and pyrimidine metabolism pathways in Drosophila. PLoS ONE 8, e62835
8. 1/S transition. Biochim. Biophys. Acta 1820, 1839-1848
9. Guinez, C., Mir, A. M., Dehennaut, V., Cacan, R., Harduin-Lepers, A., Michalski, J. C., and Lefebvre, T. (2008) Protein ubiquitination is modulated by O-GlcNAc glycosylation. FASEB J. 22, 2901-2911
10. Zachara, N. E., and Hart, G. W. (2004) O-GlcNAc modification: a nutritional sensor that modulates proteasome function. Trends Cell Biol. 14, 218-221
11. Hart, G. W., Slawson, C., Ramirez-Correa, G., and Lagerlof, O. (2011) Cross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease. Annu. Rev. Biochem. 80, 825-858
12. Itkonen, H. M., Minner, S., Guldvik, I. J., Sandmann, M. J., Tsourlakis, M. C., Berge, V., Svindland, A., Schlomm, T., and Mills, I. G. (2013) O-GlcNAc transferase integrates metabolic pathways to regulate the stability of c-MYC in human prostate cancer. Cancer Res. 73, 5277-5287
13. Ruan, H. B., Han, X., Li, M. D., Singh, J. P., Qian, K., Azarhoush, S., Zhao, L., Bennett, A. M., Samuel, V. T., Wu, J., Yates, J. R., 3rd, and Yang, X. (2012) O-GlcNAc transferase/host cell factor C1 complex regulates gluconeogenesis by modulating PGC-1α stability. Cell Metab. 16, 226-237
14. Gong, C. X., Liu, F., and Iqbal, K. (2012) O-GlcNAc cycling modulates neurodegeneration. Proc. Natl. Acad. Sci. U.S.A. 109, 17319-17320
15. Dong, D. L., and Hart, G. W. (1994) Purification and characterization of an O-GlcNAc selective N-acetyl-β-D-glucosaminidase from rat spleen cytosol. J. Biol. Chem. 269, 19321-19330
16. Heckel, D., Comtesse, N., Brass, N., Blin, N., Zang, K. D., and Meese, E. (1998) Novel immunogenic antigen homologous to hyaluronidase in meningioma. Hum. Mol. Genet. 7, 1859-1872
17. Gao, Y., Wells, L., Comer, F. I., Parker, G. J., and Hart, G. W. (2001) Dynamic O-glycosylation of nuclear and cytosolic proteins: cloning and characterization of a neutral, cytosolic β-N-acetylglucosaminidase from human brain. J. Biol. Chem. 276, 9838-9845
18. Penton, E., Poenaru, L., and Dreyfus, J. C. (1975) Hexosaminidase C in Tay-Sachs and Sandhoff disease. Biochim. Biophys. Acta 391, 162-169
19. Minami, R., Nakamura, F., Oyanagi, K., and Nakao, T. (1981) Hexosaminidase C in brain affected by Tay-Sachs disease. Tohoku J. Exp. Med. 133, 175-185
20. Swallow, D. M., Evans, L., Saha, N., and Harris, H. (1976) Characterization and tissue distribution of N-acetyl hexosaminidase C: suggestive evidence for a separate hexosaminidase locus. Ann. Hum. Genet. 40, 55-66
21. Mahuran, D. J. (1999) Biochemical consequences of mutations causing the GM2 gangliosidoses. Biochim. Biophys. Acta 1455, 105-138
22. Cantarel, B. L., Coutinho, P. M., Rancurel, C., Bernard, T., Lombard, V., and Henrissat, B. (2009) The Carbohydrate-Active enZYmes Database (CAZy): an expert resource for glycogenomics. Nucleic Acids Res. 37, D233-D238
23. Comtesse, N., Maldener, E., and Meese, E. (2001) Identification of a nuclear variant of MGEA5, a cytoplasmic hyaluronidase and a β-N-acetylglucosaminidase. Biochem. Biophys. Res. Commun. 283, 634-640
24. Sekine, O., Love, D. C., Rubenstein, D. S., and Hanover, J. A. (2010) Blocking O-linked GlcNAc cycling in Drosophila insulin-producing cells perturbs glucose-insulin homeostasis. J. Biol. Chem. 285, 38684-38691
25. Forsythe, M. E., Love, D. C., Lazarus, B. D., Kim, E. J., Prinz, W. A., Ashwell, G., Krause, M. W., and Hanover, J. A. (2006) Caenorhabditis elegans ortholog of a diabetes susceptibility locus: oga-1 (O-GlcNAcase) knockout impacts O-GlcNAc cycling, metabolism, and dauer. Proc. Natl. Acad. Sci. U.S.A. 103, 11952-11957
26. Macauley, M. S., and Vocadlo, D. J. (2009) Enzymatic characterization and inhibition of the nuclear variant of human O-GlcNAcase. Carbohydr. Res. 344, 1079-1084
27. Toleman, C., Paterson, A. J., Whisenhunt, T. R., and Kudlow, J. E. (2004) Characterization of the histone acetyltransferase (HAT) domain of a bifunctional protein with activable O-GlcNAcase andHATactivities. J. Biol. Chem. 279, 53665-53673
28. Keembiyehetty, C. N., Krzeslak, A., Love, D. C., and Hanover, J. A. (2011) A lipid-droplet-targeted O-GlcNAcase isoform is a key regulator of the proteasome. J. Cell Sci. 124, 2851-2860
29. Wells, L., Gao, Y., Mahoney, J. A., Vosseller, K., Chen, C., Rosen, A., and Hart, G. W. (2002) Dynamic O-glycosylation of nuclear and cytosolic proteins: further characterization of the nucleocytoplasmic β-N-acetylglucosaminidase, O-GlcNAcase. J. Biol. Chem. 277, 1755-1761
30. Schultz, J., and Pils, B. (2002) Prediction of structure and functional residues for O-GlcNAcase, a divergent homologue of acetyltransferases. FEBS Lett. 529, 179-182
31. Toleman, C. A., Paterson, A. J., and Kudlow, J. E. (2006) The histone acetyltransferase NCOAT contains a zinc finger-like motif involved in substrate recognition. J. Biol. Chem. 281, 3918-3925
32. Butkinaree, C., Cheung, W. D., Park, S., Park, K., Barber, M., and Hart, G. W. (2008) Characterization of β-N-acetylglucosaminidase cleavage by caspase-3 during apoptosis. J. Biol. Chem. 283, 23557-23566
33. Rao, F. V., Schüttelkopf, A. W., Dorfmueller, H. C., Ferenbach, A. T., Navratilova, I., and van Aalten, D. M. (2013) Structure of a bacterial putative acetyltransferase defines the fold of the human O-GlcNAcase C-terminal domain. Open Biol. 3, 130021
34. He, Y., Roth, C., Turkenburg, J. P., and Davies, G. J. (2014) Three-dimensional structure of a Streptomyces sviceus GNAT acetyltransferase with similarity to the C-terminal domain of the human GH84 O-GlcNAcase. Acta Crystallogr. D Biol. Crystallogr. 70, 186-195
35. Nagel, A. K., and Ball, L. E. (2014) O-GlcNAc transferase and O-GlcNAcase: achieving target substrate specificity. Amino Acids 46, 2305-2316
36. Rao, F. V., Dorfmueller, H. C., Villa, F., Allwood, M., Eggleston, I. M., and van Aalten, D. M. (2006) Structural insights into the mechanism and inhibition of eukaryotic O-GlcNAc hydrolysis. EMBO J. 25, 1569-1578
37. Dennis, R. J., Taylor, E. J., Macauley, M. S., Stubbs, K. A., Turkenburg, J. P., Hart, S. J., Black, G. N., Vocadlo, D. J., and Davies, G. J. (2006) Structure and mechanism of a bacterial β-glucosaminidase having O-GlcNAcase activity. Nat. Struct. Mol. Biol. 13, 365-371
38. Olszewski, N. E., West, C. M., Sassi, S. O., and Hartweck, L. M. (2010) O-GlcNAc protein modification in plants: evolution and function. Biochim. Biophys. Acta 1800, 49-56
39. Macauley, M. S., Whitworth, G. E., Debowski, A. W., Chin, D., and Vocadlo, D. J. (2005) O-GlcNAcase uses substrate-assisted catalysis: kinetic analysis and development of highly selective mechanism-inspired inhibitors. J. Biol. Chem. 280, 25313-25322
40. Tews, I., Perrakis, A., Oppenheim, A., Dauter, Z., Wilson, K. S., and Vorgias, C. E. (1996) Bacterial chitobiase structure provides insight into catalytic mechanism and the basis of Tay-Sachs disease. Nat. Struct. Biol. 3, 638-648
41. Cetinba, N., Macauley, M. S., Stubbs, K. A., Drapala, R., and Vocadlo, D. J. (2006) Identification of Asp174 and Asp175 as the key catalytic residues of human O-GlcNAcase by functional analysis of site-directed mutants. Biochemistry 45, 3835-3844
42. He, Y., Macauley, M. S., Stubbs, K. A., Vocadlo, D. J., and Davies, G. J. (2010) Visualizing the reaction coordinate of an O-GlcNAc hydrolase. J. Am. Chem. Soc. 132, 1807-1809
43. Schimpl, M., Schüttelkopf, A. W., Borodkin, V. S., and van Aalten, D. M. (2010) Human OGA binds substrates in a conserved peptide recognition groove. Biochem. J. 432, 1-7
44. Shen, D. L., Gloster, T. M., Yuzwa, S. A., and Vocadlo, D. J. (2012) Insights into O-linked N-acetylglucosamine ([0-9]O-GlcNAc) processing and dynamics through kinetic analysis of O-GlcNAc transferase and O-GlcNAcase activity on protein substrates. J. Biol. Chem. 287, 15395-15408
45. Schimpl, M., Borodkin, V. S., Gray, L. J., and van Aalten, D. M. (2012) Synergy of peptide and sugar in O-GlcNAcase substrate recognition. Chem. Biol. 19, 173-178
46. Martin, J. C., Fadda, E., Ito, K., and Woods, R. J. (2014) Defining the structural origin of the substrate sequence independence of O-GlcNAcase using a combination of molecular docking and dynamics simulation. Glycobiology 24, 85-96
47. Copeland, R. J., Bullen, J. W., and Hart, G. W. (2008) Cross-talk between GlcNAcylation and phosphorylation: roles in insulin resistance and glucose toxicity. Am. J. Physiol. Endocrinol. Metab. 295, E17-E28
48. Whisenhunt, T. R., Yang, X., Bowe, D. B., Paterson, A. J., Van Tine, B. A., and Kudlow, J. E. (2006) Disrupting the enzyme complex regulating O-GlcNAcylation blocks signaling and development. Glycobiology 16, 551-563
49. Banerjee, P. S., Hart, G. W., and Cho, J. W. (2013) Chemical approaches to study O-GlcNAcylation. Chem. Soc. Rev. 42, 4345-4357
50. Cecioni, S., and Vocadlo, D. J. (2013) Tools for probing and perturbing O-GlcNAc in cells and in vivo. Curr. Opin. Chem. Biol. 17, 719-728
51. Ostrowski, A., and van Aalten, D. M. (2013) Chemical tools to probe cellular O-GlcNAc signalling. Biochem. J. 456, 1-12
52. Knapp, S., Abdo, M., Ajayi, K., Huhn, R. A., Emge, T. J., Kim, E. J., and Hanover, J. A. (2007) Tautomeric modification of GlcNAc-thiazoline. Org. Lett. 9, 2321-2324
53. Whitworth, G. E., Macauley, M. S., Stubbs, K. A., Dennis, R. J., Taylor, E. J., Davies, G. J., Greig, I. R., and Vocadlo, D. J. (2007) Analysis of PUGNAc and NAG-thiazoline as transition state analogues for human O-GlcNAcase: mechanistic and structural insights into inhibitor selectivity and transition state poise. J. Am. Chem. Soc. 129, 635-644
54. Yuzwa, S. A., Macauley, M. S., Heinonen, J. E., Shan, X., Dennis, R. J., He, Y., Whitworth, G. E., Stubbs, K. A., McEachern, E. J., Davies, G. J., and Vocadlo, D. J. (2008) A potent mechanism-inspired O-GlcNAcase inhibitor that blocks phosphorylation of tau in vivo. Nat. Chem. Biol. 4, 483-490
55. Laczy, B., Marsh, S. A., Brocks, C. A., Wittmann, I., and Chatham, J. C. (2010) Inhibition of O-GlcNAcase in perfused rat hearts by NAG-thiazolines at the time of reperfusion is cardioprotective in an O-GlcNAc-dependent manner. Am. J. Physiol. Heart Circ. Physiol. 299, H1715-H1727
56. Hilgers, R. H., Xing, D., Gong, K., Chen, Y. F., Chatham, J. C., and Oparil, S. (2012) Acute O-GlcNAcylation prevents inflammation-induced vascular dysfunction. Am. J. Physiol. Heart Circ. Physiol. 303, H513-H522
57. Lefebvre, T., Ferreira, S., Dupont-Wallois, L., Bussière, T., Dupire, M. J., Delacourte, A., Michalski, J. C., and Caillet-Boudin, M. L. (2003) Evidence of a balance between phosphorylation and O-GlcNAc glycosylation of Tau proteins - a role in nuclear localization. Biochim. Biophys. Acta 1619, 167-176
58. Liu, F., Iqbal, K., Grundke-Iqbal, I., Hart, G. W., and Gong, C. X. (2004) O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 101, 10804-10809
59. Yu, Y., Zhang, L., Li, X., Run, X., Liang, Z., Li, Y., Liu, Y., Lee, M. H., Grundke-Iqbal, I., Iqbal, K., Vocadlo, D. J., Liu, F., and Gong, C. X. (2012) Differential effects of an O-GlcNAcase inhibitor on tau phosphorylation. PLoS ONE 7, e35277
60. Yuzwa, S. A., Shan, X., Macauley, M. S., Clark, T., Skorobogatko, Y., Vosseller, K., and Vocadlo, D. J. (2012) Increasing O-GlcNAc slows neurodegeneration and stabilizes tau against aggregation. Nat. Chem. Biol. 8, 393-399
61. Graham, D. L., Gray, A. J., Joyce, J. A., Yu, D., O'Moore, J., Carlson, G. A., Shearman, M. S., Dellovade, T. L., and Hering, H. (2014) Increased O-GlcNAcylation reduces pathological tau without affecting its normal phosphorylation in a mouse model of tauopathy. Neuropharmacology 79, 307-313
62. Dorfmueller, H. C., Borodkin, V. S., Schimpl, M., and van Aalten, D. M. (2009) GlcNAcstatins are nanomolar inhibitors of human O-GlcNAcase inducing cellular hyper-O-GlcNAcylation. Biochem. J. 420, 221-227
63. Macauley, M. S., Chan, J., Zandberg, W. F., He, Y., Whitworth, G. E., Stubbs, K. A., Yuzwa, S. A., Bennet, A. J., Varki, A., Davies, G. J., and Vocadlo, D. J. (2012) Metabolism of vertebrate amino sugars with N-glycolyl groups: intracellular β-O-linked N-glycolylglucosamine (GlcNGc), UDP-GlcNGc, and the biochemical and structural rationale for the substrate tolerance of β-O-linked β-N-acetylglucosaminidase. J. Biol. Chem. 287, 28882-28897
64. Stryke, D., Kawamoto, M., Huang, C. C., Johns, S. J., King, L. A., Harper, C. A., Meng, E. C., Lee, R. E., Yee, A., L'Italien, L., Chuang, P. T., Young, S. G., Skarnes, W. C., Babbitt, P. C., and Ferrin, T. E. (2003) BayGenomics: a resource of insertional mutations in mouse embryonic stem cells. Nucleic Acids Res. 31, 278-281
65. Dorfmueller, H. C., Borodkin, V. S., Schimpl, M., Zheng, X., Kime, R., Read, K. D., and van Aalten, D. M. (2010) Cell-penetrant, nanomolar O-GlcNAcase inhibitors selective against lysosomal hexosaminidases. Chem. Biol. 17, 1250-1255
66. Pathak, S., Borodkin, V. S., Albarbarawi, O., Campbell, D. G., Ibrahim, A., and van Aalten, D. M. (2012) O-GlcNAcylation of TAB1 modulates TAK1-mediated cytokine release. EMBO J. 31, 1394-1404
67. Speakman, C. M., Domke, T. C., Wongpaiboonwattana, W., Sanders, K., Mudaliar, M., van Aalten, D. M., Barton, G. J., and Stavridis, M. P. (2014) Elevated O-GlcNAc levels activate epigenetically repressed genes and delay mouse ES cell differentiation without affecting naive to primed cell transition. Stem Cells 32, 2605-2615
68. Hu, Y., Belke, D., Suarez, J., Swanson, E., Clark, R., Hoshijima, M., and Dillmann, W. H. (2005) Adenovirus-mediated overexpression of O-GlcNAcase improves contractile function in the diabetic heart. Circ. Res. 96, 1006-1013
69. Robinson, K. A., Ball, L. E., and Buse, M. G. (2007) Reduction of O-GlcNAc protein modification does not prevent insulin resistance in 3T3-L1 adipocytes. Am. J. Physiol. Endocrinol. Metab. 292, E884-E890
70. Macauley, M. S., Shan, X., Yuzwa, S. A., Gloster, T. M., and Vocadlo, D. J. (2010) Elevation of global O-GlcNAc in rodents using a selective O-GlcNAcase inhibitor does not cause insulin resistance or perturb glucohomeostasis. Chem. Biol. 17, 949-958
71. Macauley, M. S., He, Y., Gloster, T. M., Stubbs, K. A., Davies, G. J., and Vocadlo, D. J. (2010) Inhibition of O-GlcNAcase using a potent and cell-permeable inhibitor does not induce insulin resistance in 3T3-L1 adipocytes. Chem. Biol. 17, 937-948
72. Slawson, C., Zachara, N. E., Vosseller, K., Cheung, W. D., Lane, M. D., and Hart, G. W. (2005) Perturbations in O-linked β-N-acetylglucosamine protein modification cause severe defects in mitotic progression and cytokinesis. J. Biol. Chem. 280, 32944-32956
73. Francisco, H., Kollins, K., Varghis, N., Vocadlo, D., Vosseller, K., and Gallo, G. (2009) O-GlcNAc post-translational modifications regulate the entry of neurons into an axon branching program.Dev. Neurobiol. 69, 162-173
74. Hayakawa, K., Hirosawa, M., Tabei, Y., Arai, D., Tanaka, S., Murakami, N., Yagi, S., and Shiota, K. (2013) Epigenetic switching by the metabolism-sensing factors in the generation of orexin neurons from mouse embryonic stem cells. J. Biol. Chem. 288, 17099-17110
75. Libina, N., Berman, J. R., and Kenyon, C. (2003) Tissue-specific activities of C. elegans DAF-16 in the regulation of lifespan. Cell 115, 489-502
76. Rahman, M. M., Stuchlick, O., El-Karim, E. G., Stuart, R., Kipreos, E. T., and Wells, L. (2010) Intracellular protein glycosylation modulates insulin mediated lifespan in C. elegans. Aging 2, 678-690
77. Wang, P., Lazarus, B. D., Forsythe, M. E., Love, D. C., Krause, M. W., and Hanover, J. A. (2012) O-GlcNAc cycling mutants modulate proteotoxicity in Caenorhabditis elegans models of human neurodegenerative diseases. Proc. Natl. Acad. Sci. U.S.A. 109, 17669-17674
78. Wang, P., and Hanover, J. A. (2013) Nutrient-driven O-GlcNAc cycling influences autophagic flux and neurodegenerative proteotoxicity. Autophagy 9, 604-606
79. Radermacher, P. T., Myachina, F., Bosshardt, F., Pandey, R., Mariappa, D., Müller, H. A., and Lehner, C. F. (2014) O-GlcNAc reports ambient temperature and confers heat resistance on ectotherm development. Proc. Natl. Acad. Sci. U.S.A. 111, 5592-5597
80. Webster, D. M., Teo, C. F., Sun, Y., Wloga, D., Gay, S., Klonowski, K. D., Wells, L., and Dougan, S. T. (2009) O-GlcNAc modifications regulate cell survival and epiboly during zebrafish development. BMC Dev. Biol. 9, 28
81. Lepage, S. E., and Bruce, A. E. (2010) Zebrafish epiboly: mechanics and mechanisms. Int. J. Dev. Biol. 54, 1213-1228
82. Yang, Y. R., Song, M., Lee, H., Jeon, Y., Choi, E. J., Jang, H. J., Moon, H. Y., Byun, H. Y., Kim, E. K., Kim, D. H., Lee, M. N., Koh, A., Ghim, J., Choi, J. H., Lee-Kwon, W., Kim, K. T., Ryu, S. H., and Suh, P. G. (2012) O-GlcNAcase is essential for embryonic development and maintenance of genomic stability. Aging Cell 11, 439-448
83. Zhu, Y., Shan, X., Yuzwa, S. A., and Vocadlo, D. J. (2014) The emerging link between O-GlcNAc and Alzheimer disease. J. Biol. Chem. 289, 34472-34481